FLONASE ALLERGY RELIEF
· Patent Litigation & Settlement History ↓
Current GenericRadar decision
Current official Orange Book exact product Type=OTC. Excluded under guideline section 4 OTC-only rule. Historical prescription status and switch effective date are not asserted.
Patent estate
| Patent | Effective date | Official listing | TRUE_DS | DS grade | Claim classification / basis | PTE | PED | Family |
|---|---|---|---|---|---|---|---|---|
| No patent facts are recorded for this product. | ||||||||
Regulatory exclusivity
| Code | Start date | End date | Scope | Entire product | All indications | Full coverage date | Combination | Source |
|---|---|---|---|---|---|---|---|---|
| No exclusivity facts are recorded in this product snapshot. | ||||||||
2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE
Generic approval evidence
| Application / product | Event | Final date | Tentative date | Applicant | Authorized generic | Exact mapping | Source |
|---|---|---|---|---|---|---|---|
| 076504 / 001 | FINAL_APPROVAL · FINAL_APPROVED | 2006-02-22 | — | HIKMA PHARMACEUTICALS USA INC | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 077538 / 001 | FINAL_APPROVAL · FINAL_APPROVED | 2007-09-12 | — | APOTEX INC | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 077570 / 001 | FINAL_APPROVAL · FINAL_APPROVED | 2008-01-16 | — | HIKMA PHARMACEUTICALS USA INC | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 078492 / 001 | FINAL_APPROVAL · FINAL_APPROVED | 2012-01-09 | — | CHARTWELL RX SCIENCES LLC | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 208150 / 001 | FINAL_APPROVAL · FINAL_APPROVED | 2016-02-29 | — | APOTEX INC | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 207957 / 001 | FINAL_APPROVAL · FINAL_APPROVED | 2016-05-26 | — | HIKMA PHARMACEUTICALS USA INC | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 208024 / 001 | FINAL_APPROVAL · FINAL_APPROVED | 2019-04-17 | — | HIKMA PHARMACEUTICALS USA INC | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 217088 / 001 | FINAL_APPROVAL · FINAL_APPROVED | 2024-05-10 | — | AUROBINDO PHARMA LTD | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 218321 / 001 | FINAL_APPROVAL · FINAL_APPROVED | 2025-06-05 | — | RUBICON RESEARCH LTD | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 219060 / 001 | FINAL_APPROVAL · FINAL_APPROVED | 2025-08-15 | — | RUBICON RESEARCH LTD | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 218742 / 001 | FINAL_APPROVAL · FINAL_APPROVED | 2026-03-16 | — | GLENMARK SPECIALTY SA | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
| 219232 / 001 | FINAL_APPROVAL · FINAL_APPROVED | 2026-08-18 | — | GLENMARK SPECIALTY SA | N | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source |
Market Entry Information
API filings, authorized generics and linked regulatory milestones.
API Master Files & Certifications 0 records
Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.
| API | Holder / manufacturer | Holder country | Filing type | Number | Status | Filed date | Available for reference | Source | Last verified |
|---|---|---|---|---|---|---|---|---|---|
| No master-file or certification records are linked through public manufacturer portfolios. | |||||||||
Authorized Generics 0 records
Authorized generics are shown separately from independent ANDA approvals.
| Application / product | Applicant | Event / status | First marketed | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|
| No authorized-generic records are linked to this product. | ||||||
Tentative ANDA Approvals 0 records
Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.
| Application / product | Applicant | Event / status | Tentative date | Follow-up final approval | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|---|
| No tentative-approval records are linked to this product. | |||||||
Paragraph IV Challenges 0 records
Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.
| Application / product | Applicant | Event / status | Certification event date | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|
| No structured Paragraph IV certification events are linked in the available approval evidence. | ||||||
Final ANDA Approvals 12 records
Approval dates do not establish commercial launch. Product mapping is shown for each linked record.
| Application / product | Applicant | Event / status | Final approval date | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|
| 076504 / 001 | HIKMA PHARMACEUTICALS USA INC | FINAL_APPROVAL · FINAL_APPROVED | 2006-02-22 | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 077538 / 001 | APOTEX INC | FINAL_APPROVAL · FINAL_APPROVED | 2007-09-12 | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 077570 / 001 | HIKMA PHARMACEUTICALS USA INC | FINAL_APPROVAL · FINAL_APPROVED | 2008-01-16 | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 078492 / 001 | CHARTWELL RX SCIENCES LLC | FINAL_APPROVAL · FINAL_APPROVED | 2012-01-09 | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 208150 / 001 | APOTEX INC | FINAL_APPROVAL · FINAL_APPROVED | 2016-02-29 | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 207957 / 001 | HIKMA PHARMACEUTICALS USA INC | FINAL_APPROVAL · FINAL_APPROVED | 2016-05-26 | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 208024 / 001 | HIKMA PHARMACEUTICALS USA INC | FINAL_APPROVAL · FINAL_APPROVED | 2019-04-17 | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 217088 / 001 | AUROBINDO PHARMA LTD | FINAL_APPROVAL · FINAL_APPROVED | 2024-05-10 | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 218321 / 001 | RUBICON RESEARCH LTD | FINAL_APPROVAL · FINAL_APPROVED | 2025-06-05 | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 219060 / 001 | RUBICON RESEARCH LTD | FINAL_APPROVAL · FINAL_APPROVED | 2025-08-15 | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 218742 / 001 | GLENMARK SPECIALTY SA | FINAL_APPROVAL · FINAL_APPROVED | 2026-03-16 | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
| 219232 / 001 | GLENMARK SPECIALTY SA | FINAL_APPROVAL · FINAL_APPROVED | 2026-08-18 | EXACT_PRODUCT · PENDING_PRODUCT_MAPPING | Source | — |
Decision evidence (1)
| Type | Date | Role | Basis | Source |
|---|---|---|---|---|
| PRODUCT_STATUS | — | EXCLUSION_BASIS | Exact application/product matched to current Orange Book Type=OTC; no patent or generic conclusion inferred. | Source |
Litigation & Settlement History
Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.
No litigation or settlement record currently linked to this product.